DURHAM, NC – Durham-based Slate Pharmaceuticals Inc. has raised $1.99 million selling mixed securities, according to a regulatory filing. The company focuses on products to treat certain afflictions of maturing men and women. (more…)
BONITA SPRINGS, FL – Tigris Pharmaceuticals Inc., a drug development company, has completed a private placement of Series C Convertible Preferred Stock resulting in gross proceeds of approximately $6.5 million. (more…)
RESEARCH TRIANGLE PARK, NC – ZenBio Inc. has been awarded a Phase II SBIR grant to continue its breast cancer research program. The $1.2 million award from the National Institutes of Health will fund studies to isolate and characterize primary basal and luminal mammary ductal cells from cancerous and non-cancerous human breast tissue. (more…)
BOCA RATON, FL – Watermark Medical Inc., a medical products and services company servicing patients suffering from sleep-disordered breathing, has closed a $6 million equity investment from Ballast Point Ventures, extending the round led by CA Technologies earlier in 2010. (more…)
DURHAM, NC- CuraxisPharmaceutical Corp., which is developing a promising treatment for Alzheimer’s Disease, has entered a $25 million equity credit deal with Southbridge Partners II. (more…)
NORCROSS, GA–Guided Therapeutics Inc. (GT) (OTCBB: GTHP) has completed a private financing of approximately $3 million. (more…)
DURHAM, NC – Tryton Medical Inc., a developer of stents designed to treat bifurcation lesions, has closed a $20 million Series D round of financing. Private healthcare investor Arnerich Massena led the financing. Current investors PTV Sciences, RiverVest Venture Partners and Spray Venture Partners participated. (more…)
BURLINGTON, N.C.–Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH), today announced that it has entered into a definitive agreement under which LabCorp will acquire Genzyme Genetics, a business unit of Genzyme Corp. (NASDAQ: GENZ), in an all cash transaction valued at $925 million. Net of expected income tax benefits, less acquisition-related expenses, the acquisition has a net cash cost to LabCorp of approximately $795 million. (more…)
ATLANTA, GA - St. Jude Medical has invested $60 million in CardioMEMS, a Georgia company that has developed a wireless cardiac monitoring device, acquiring 19 percent stake in the company. And, as the Minneapolis Star-Tribune points out, St. Jude could buy CardioMEMSÂ outright for an additional $375 million if certain milestones are met.
(more…)
JUPITER, FL – Dyadic International Inc. (Pink Sheets: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, has received an additional $1 million to complete its previously announced private placement of convertible subordinated secured promissory notes. That brings its gross proceeds to $4 million. (more…)
